Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer
Geburtshilfe und Frauenheilkunde · 01.06.2024 · 84 (06) · 529-540
DOI: 10.1055/a-2300-5326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 01.06.2024. Verfasst von Rachel Würstlein und 29 weiteren Autor:innen. Beteiligte Einrichtung: Breast Center, Department of Gynecology and Obstetrics and CCC Munich LMU, LMU University Hospital, Munich, Germany. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Clinical evidence is interpreted based on clinical studies and personal experience which can lead to different interpretations of data. This makes the opinions issued by panels of experts such as the Advanced Breast Cancer Panel which convened in November 2023 for the seventh time (ABC7) particularly important. At the conference, current issues around advanced breast cancer were evaluated by an international team of experts. In 2023 the data on CDK4/6 inhibitors was so extensive that the answers to questions about the sequencing of therapy and the potential use of chemotherapy as an alternative therapy were relatively clear. Moreover, data on antibody drug conjugates which provides a good overview of their uses is available for all molecular subtypes. Some therapeutic settings, including patients with brain metastases or leptomeningeal disease, older patients, locally advanced breast cancer and visceral crises, continue to be particularly important and were discussed in structured sessions. The scientific context of some of the topics discussed at ABC7 is presented and assessed here.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Breast Center, Department of Gynecology and Obstetrics and CCC Munich LMU, LMU University Hospital, Munich, Germany.
- Department of Gynecology and Obstetrics, Marienhospital Bottrop, Bottrop, Germany.
- Department of Gynecology and Obstetrics, Tübingen University Hospital, Tübingen, Germany.
- Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf) Germany.
- Onkologie Aschaffenburg, Aschaffenburg, Germany.
- Gynäkologie und Geburtshilfe, Diakonissen-Stiftungs-Krankenhaus Speyer, Speyer, Germany.
Zitieren
APA
Würstlein, R., Kolberg, H. C., Hartkopf, A. D., Fehm, T. N., Welslau, M., Schütz, F., Fasching, P. A., Janni, W., Witzel, I., Thomssen, C., Krückel, A., Belleville, E., Lüftner, D., Untch, M., Thill, M., Hörner, M., Tesch, H., Ditsch, N., Lux, M. P., …, & Müller, V. (2024). Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer. Geburtshilfe und Frauenheilkunde, 84(06), 529-540. https://doi.org/10.1055/a-2300-5326
Vancouver
Würstlein R, Kolberg HC, Hartkopf AD, Fehm TN, Welslau M, Schütz F, et al. Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer. Geburtshilfe und Frauenheilkunde. 2024;84(06):529-540. doi:10.1055/a-2300-5326
BibTeX
@article{Wrstlein2024,
author = {Würstlein, Rachel and Kolberg, Hans-Christian and Hartkopf, Andreas D and Fehm, Tanja N and Welslau, Manfred and Schütz, Florian and Fasching, Peter A and Janni, Wolfgang and Witzel, Isabell and Thomssen, Christoph and Krückel, Annika and Belleville, Erik and Lüftner, Diana and Untch, Michael and Thill, Marc and Hörner, Manuel and Tesch, Hans and Ditsch, Nina and Lux, Michael P and Aktas, Bahriye and Banys-Paluchowski, Maggie and Taran, Florin-Andrei and Wöckel, Achim and Harbeck, Nadia and Stickeler, Elmar and Bartsch, Rupert and Schneeweiss, Andreas and Ettl, Johannes and Krug, David and Müller, Volkmar},
title = {Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer},
journal = {Geburtshilfe und Frauenheilkunde},
year = {2024},
volume = {84},
number = {06},
pages = {529--540},
doi = {10.1055/a-2300-5326}
}
EUVIMED